ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

IgM HLA DSAs Do Not Alter the Outcomes of Renal Allograft Rejection

A. Gueret-Wardle,1 P. Dodd,1 G. Lucisano,1 S. Hassan,1 P. Brookes,2 E. Santos-Nunez,2 N. Firmin,2 D. Goodall,1 C. Roufosse,1 M. Willicombe,1 D. Taube.1

1Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom
2Histocompatibility and Immunogenetics, Imperial College Healthcare NHS Trust, London, United Kingdom.

Meeting: 2018 American Transplant Congress

Abstract number: A20

Keywords: Antibodies, Graft survival, Kidney transplantation, Rejection

Session Information

Date: Saturday, June 2, 2018

Session Name: Poster Session A: Biomarkers, Immune Monitoring and Outcomes

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Related Abstracts
  • The Impact of Therapy On the Inflammatory Infiltrate in Renal Allografts With Acute and Chronic Antibody Mediated Rejection
  • Impact of a B-Cell Targeting Agent on Antibody Mediated Rejection and Graft' Survival in Liver Transplantation with Preformed DSAs.

Introduction: whilst IgG HLA DSAs are associated with renal allograft rejection and graft loss, the role of IgM HLA DSAs is controversial. We investigate the significance of de novo IgM HLA DSAs in patients with T-Cell mediated rejection [TCMR], acute antibody mediated rejection [aAMR] and chronic antibody mediated rejection [cAMR].

Methods: 1667 CDC/FCXM negative renal transplant recipients receiving a steroid sparing, tacrolimus based regimen with monoclonal antibody induction were studied. We investigated 50 with TCMR, 50 with aAMR and 57 with cAMR. Patients were screened at the time of biopsy for IgG and IgM DSAs and compared with 50 control, unsensitised recipients with normal surveillance biopsies. Diagnosis of rejection was based on Banff criteria. Graft survival was compared in each cohort and categorised; IgG-/IgM-, IgG+/IgM-, IgG-/IgM+ and IgG+/IgM+.

Results: incidence of IgM DSAs in the aAMR group was 10/50 (20%), 5/50 (10%) in the TCR group, 18/57 (32%) in the cAMR group and 6/50 (12%) in the normal controls. Graft survival in the presence of an IgM DSA was not inferior in the aAMR/TCR groups when compared to controls and only significantly inferior in those groups with an IgG DSA (p=0.005).

Graft survival in the presence of an IgM DSA was not inferior in the cAMR/TCR when compared to controls and only significantly inferior in those groups with an IgG DSA (p<0.001).

Discussion: this study demonstrates that the presence of an IgM DSA alone or in association with an IgG DSA does not result in inferior outcomes. It is the presence of an IgG DSA in allograft rejection which significantly reduces graft survival.

CITATION INFORMATION: Gueret-Wardle A., Dodd P., Lucisano G., Hassan S., Brookes P., Santos-Nunez E., Firmin N., Goodall D., Roufosse C., Willicombe M., Taube D. IgM HLA DSAs Do Not Alter the Outcomes of Renal Allograft Rejection Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gueret-Wardle A, Dodd P, Lucisano G, Hassan S, Brookes P, Santos-Nunez E, Firmin N, Goodall D, Roufosse C, Willicombe M, Taube D. IgM HLA DSAs Do Not Alter the Outcomes of Renal Allograft Rejection [abstract]. https://atcmeetingabstracts.com/abstract/igm-hla-dsas-do-not-alter-the-outcomes-of-renal-allograft-rejection/. Accessed December 6, 2019.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.